Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

www.positron.comSep 19 2009

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend MedAxiom’s Fall Conference in Dana Point, California September 23^rd, 2009 to promote their cardiac optimized PET scanner, the Attrius™ (www.medaxiom.com).

The MedAxiom conferences keep its members informed of changing trends, technologies, strategies and best practices in cardiology-practice administration and service delivery. “The MedAxiom Fall Conference attracts a mix of cardiology practice attendees with approximately 75% of current attendees being CEO’s and other high-level administrators, and the other 25% being cardiologists. We now have over 108 practices registered so it looks as though we’re anticipating another great conference,” says Chris Romeo, Vice President of Corporate Relations for MedAxiom.

Since joining the MedAxiom group in July, Positron has introduced and informed the MedAxiom members about current and proposed reimbursement pricings, the clinical and cost efficacy of PET and the benefits of the Attrius™, Positron’s Cardiac PET Scanner. In preparation for the Fall Conference, Positron recently hosted an educational Webinar where MedAxiom members learned about the low cost of entry, lower patient radiation exposure, competitive scan times and the clinical and cost efficacies of Cardiac PET. The members also participated in a thorough Q&A session with Positron’s Clinical Specialists. Peter Webner, RT(N), CNMT Northeast Regional Business Director at Positron states, “The Webinar was a great vehicle to introduce Positron and our message for the upcoming MedAxiom Fall Conference. Positron’s MedAxiom membership has been a tremendous means to reach our target audience and the interest in our products and services are evident. We deliver the best full cardiac solution and look forward for the opportunity to communicate that directly with the administrators, cardiologists and technologists who attend. Mr. Webner further states Positron’s focus has been to inform that Cardiovascular PET imaging enables the Physician to provide better care. In the past, many Cardiologists have not explored Cardiovascular PET due to the size and cost of the oncology-focused PET/CT devices currently on the market. Positron is changing the paradigm. Positron’s Attrius™ provides the opportunity for the Physician to provide superior care with a device that is designed by Cardiologists for Cardiologists. The small footprint, robust standard cardiovascular software package and reasonable price point all make this technology a viable choice for enhancing the capabilities of Cardiovascular practices, while providing better care.”